Treating to New Targets (TNT) trial

Study / Research

One of the first trials that demonstrated incremental benefits in cardiovascular outcomes by reducing LDL levels through increased statin dose.

Mentioned in 1 video

Videos Mentioning Treating to New Targets (TNT) trial

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

One of the first trials that demonstrated incremental benefits in cardiovascular outcomes by reducing LDL levels through increased statin dose.